Education & Training

Medical School

Monash University

Residency

Pediatric Neurology

  • University of Texas Health Science Center-Houston

Fellowship

Epilepsy

  • University of Texas Health Science Center-Houston

Boards

American Board of Psychiatry & Neurology-Neurophysiology
American Board of Psychiatry & Neurology-Epilepsy

Insurances

MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.

Academic Information

Areas of Expertise

  • Seizures & epilepsy, especially quality of life
  • Lennox-Gastaut syndrome & epileptic encephalopathy
  • Status epilepticus
  • Antiseizure medications
  • Hypothalamic hamartomas
  • Epilepsy surgery

Awards & Honors

  • Certificate of Appreciation for Excellence in Teaching. Neurology Residency Program, Department of Neurology, University of Texas-Houston Medical School, July 1, 2001 – June 30, 2002.
  • “Levetiracetam: Pediatric Experience”. Winner, Young Investigator Award Texas Neurological Society, Annual Winter Conference, Austin on February 23, 2002.
  • “Childhood Mesial Temporal Sclerosis”. Winner, Journal of Child Neurology (JCN)/Decker Neuroscience Prize, 28th Annual Southern Pediatric Neurology Society Meeting, New Orleans on March 15, 2003.
  • “Video EEG is Unnecessary and Can be Misleading in Seizures Symptomatic to Hypothalamic Hamartomas”. Winner, Journal of Child Neurology (JCN)/Decker Neuroscience Prize, 29th Annual Southern Pediatric Neurology Society Meeting, New Orleans on March 13, 2004.
  • Co-Director of the17th Annual Epilepsy Update, “Problems & Solutions for Epilepsy Management”. Jointly sponsored by the Barrow Neurological Institute, Epilepsy Foundation of Arizona, Mayo Clinic Scottsdale and University of Arizona College of Medicine, November 6, 2004.
  • “Intravenous levetiracetam in children: a prospective safety study”. Hastriter E, Ng Y-t. Winner, Journal of Child Neurology/Sage Neuroscience Prize, 34th Annual Southern Pediatric Neurology Society Meeting, New Orleans, March 21, 2009.
  • “Intravenous levetiracetam in children: a prospective safety study”. Hastriter E, Ng Y-t, Cardenas J, Khoury E, Chapman K. First prize (oral presentation) St. Joseph’s Hospital Academic Excellence Day, Phoenix, May 8, 2009.
  • “Simple Febrile Seizures Plus (SFS+): It is okay to have more than one seizure within a 24-hour period”. Grill MF, Ng Y-t. Third prize (oral presentation) St. Joseph’s Hospital Academic Excellence Day, Phoenix, May 8, 2009.
  • A.B. Baker Teaching Award, from the American Academy of Neurology 2016.
  • Superstar Faculty (Teaching) Award, “Most Likely to Turn Heads” June 16, 2016. Baylor College of Medicine Pediatric Residents at the Children’s Hospital of San Antonio 2015-2016.

Who’s Who in Medicine and Healthcare

  • 2004 - Included in “Guide to America’s Top Physicians”
  • 2005 - Included in the 33rd Edition of the Dictionary of International Biography
  • 2006 – University of Oklahoma Department of Pediatrics Outstanding faculty Teaching Award to Pediatric Education, 2012-2013

Publications

  • Ahmad S, Ahmad K, Ng YT.
    Neonatal epileptic encephalopathies.
    Semin Pediatr Neurol 2021;37:Apr Epub 2021 Mar 4.
  • Vossler DG, Knake S, O'Brien TJ, Watanabe M, Brock M, Steiniger-Brach B, Williams P, Roebling R; SP0982 co-investigators.
    Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
    J Neurol Neurosurg Psychiatry. 2020;91:1067-1075.
  • Gellman SR, Ng YT.*
    Transient corpus callosal lesion presenting with alien hand syndrome.
    Pediatr Neurol 2018;89:66-67.
  • Tavella SK, Ng YT.*
    Saving PHACE.
    Pediatr Neurol 2018;85:82-83.
  • Moresco BL, Svoboda MD, Ng YT.*
    A quiet disease with loud manifestations.
    Semin Pediatr Neurol 2018;26:88-91.
  • Sabroske E, Svoboda MD, Ng YT.*
    Passing the newborn hearing screen does not exclude congenitally acquired infectious hearing loss.
    Pediatr Neurol 2018;83:60-61.
  • Khawaja AM, Pati S, Ng YT*.
    Management of epilepsy due to hypothalamic hamartomas.
    Pediatr Neurol 2017;75:29-42.
  • Ostendorf AP, Ng YT.
    Treatment-resistant Lennox-Gastaut Syndrome: therapeutic trends, challenges and future directions.
    Neuropsychiatr Dis Treat 2017;13:1131-1140.
  • Shih JJ, Whitlock JB, Chimato N, Vargas E, Karceski SC, Frank RD.
    Epilepsy treatment in adults and adolescents: Expert opinion, 2016.
    Epilepsy Behav. 2017;69:186-222. Review.
    Epilepsy Expert Consensus Panel: Ng Y-T.
  • Ahmad KA, Desai SJ, Bennet MM, Ahmad SF, Ng Y-T, Clark RH, Tolia VN.
    Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005-2014.
    J Perinatol 2016;37:296-300.
  • Poddar K, Sharma R, Ng YT.*
    Intravenous lacosamide in pediatric status epilepticus: an open-label Efficacy and Safety Study.
    Pediatr Neurol 2016;61:83-86.
  • Fesler JR, Kanaan S, Mapstone TB, Ng YT.*
    Reversible Lennox-Gastaut Syndrome: an Exemplary Case of Curative Focal Heterotopia Resection.
    J Neurol Neurophysiol 2015;6:e16.
  • Mittal M, Harrison DL, Thompson DM, Miller MJ, Farmer KC, Ng YT.* An evaluation of three statistical estimation methods for assessing health policy effects on prescription drug claims. Res Social Adm Pharm 2016;12:29-40.
  • Ng YT, Conry J, Mitchell WG, Buchhalter J, Isojarvi J, Lee D, Drummond R, Chung S.
    Clobazam is equally safe and efficacious for seizures associated with Lennox-Gastaut syndrome across different age groups: Post hoc analyses of short- and long-term clinical trial results.
    Epilepsy Behav 2015;46:221-226.
  • Ahmad S, Ng YT.
    Focal and Multifocal Seizures (Experts Explain).
    Childneurochannel.org April 2015.
  • Mittal M, Harrison DL, Miller MJ, Farmer KC, Thomson DM, Ng YT.*
    Has the Antiepileptic Drug (AED) Prescription Claims Changed Following the FDA Suicidality Warning: an Evaluation in a State Medicaid Program.
    Epilepsy Behav 2014;34:109-15.